-
2
-
-
84942345993
-
-
Elsevier: London, UK; Academic Press: Cambridge, MA, USA
-
Arseniy, E.Y.; Anton, G.K. Interleukins in Cancer Biology: Their Heterogeneous Role; Elsevier: London, UK; Academic Press: Cambridge, MA, USA, 2014; ISBN 9780128013335.
-
(2014)
Interleukins in Cancer Biology: Their Heterogeneous Role
-
-
Arseniy, E.Y.1
Anton, G.K.2
-
3
-
-
0004623751
-
-
6th ed.; W. H. Freeman: New York, NY, USA
-
Lodish, H.; Berk, A.; Zipursky, S.L.; Kaiser, C.A.; Krieger, M.; Scott, M.P.; Bretscher, A.; Ploegh, H.; Matsudaira, P. Molecular Biology of the Cell, 6th ed.; W. H. Freeman: New York, NY, USA, 2000; ISBN-13: 978-0716776017.
-
(2000)
Molecular Biology of the Cell
-
-
Lodish, H.1
Berk, A.2
Zipursky, S.L.3
Kaiser, C.A.4
Krieger, M.5
Scott, M.P.6
Bretscher, A.7
Ploegh, H.8
Matsudaira, P.9
-
4
-
-
84920272734
-
Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
-
CrossRefPubMed
-
Venkatesha, S.H.; Dudics, S.; Acharya, B.; Moudgil, K.D. Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy. Int. J. Mol. Sci.2015, 16, 887-906. [CrossRef] [PubMed]
-
(2015)
Int. J. Mol. Sci
, vol.16
, pp. 887-906
-
-
Venkatesha, S.H.1
Dudics, S.2
Acharya, B.3
Moudgil, K.D.4
-
5
-
-
84918809100
-
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
-
CrossRef
-
Duque, A.G.; Descoteaux, A. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases. Front. Immunol. 2014, 5, 491. [CrossRef]
-
(2014)
Front. Immunol
, vol.5
, pp. 491
-
-
Duque, A.G.1
Descoteaux, A.2
-
6
-
-
84941643421
-
Low Serum Levels of Interleukin 35 in Patients with Rheumatoid Arthritis
-
CrossRefPubMed
-
Ning, X.; Jian, Z.; Wang, W. Low Serum Levels of Interleukin 35 in Patients with Rheumatoid Arthritis. Tohoku J. Exp. Med. 2015, 237, 77-82. [CrossRef] [PubMed]
-
(2015)
Tohoku J. Exp. Med
, vol.237
, pp. 77-82
-
-
Ning, X.1
Jian, Z.2
Wang, W.3
-
7
-
-
0026095666
-
Defining protective responses to pathogens: Cytokine profiles in leprosy lesions
-
CrossRefPubMed
-
Yamamura, M.; Uyemura, K.; Deans, R.J.; Weinberg, K.; Rea, T.H.; Bloom, B.R.; Modin, R.L. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions. Science 1991, 254, 277-279. [CrossRef] [PubMed]
-
(1991)
Science
, vol.254
, pp. 277-279
-
-
Yamamura, M.1
Uyemura, K.2
Deans, R.J.3
Weinberg, K.4
Rea, T.H.5
Bloom, B.R.6
Modin, R.L.7
-
8
-
-
84891360395
-
Multifarious determinants of cytokine receptor signaling specificity
-
CrossRefPubMed
-
Moraga, I.; Spangler, J.; Mendoza, J.L.; Garcia, C.K. Multifarious determinants of cytokine receptor signaling specificity. Adv. Immunol. 2014, 121, 1-39. [CrossRef] [PubMed]
-
(2014)
Adv. Immunol
, vol.121
, pp. 1-39
-
-
Moraga, I.1
Spangler, J.2
Mendoza, J.L.3
Garcia, C.K.4
-
9
-
-
85008946422
-
Biologics for Targeting Inflammatory Cytokines, Clinical Uses and Limitations
-
CrossRefPubMed
-
Rider, P.; Carmi, Y.; Cohen, I. Biologics for Targeting Inflammatory Cytokines, Clinical Uses and Limitations. Int. J. Cell Biol. 2016, 7, 1-11. [CrossRef] [PubMed]
-
(2016)
Int. J. Cell Biol.
, vol.7
, pp. 1-11
-
-
Rider, P.1
Carmi, Y.2
Cohen, I.3
-
10
-
-
84873305409
-
An introduction to immunology and immunopathology
-
CrossRefPubMed
-
Warrington, R.; Watson, W.; Kim, H.L.; Antonetti, F.R. An introduction to immunology and immunopathology. Allergy Asthma Clin. Immunol. 2011, 7, S1. [CrossRef] [PubMed]
-
(2011)
Allergy Asthma Clin. Immunol
, vol.7
, pp. 1
-
-
Warrington, R.1
Watson, W.2
Kim, H.L.3
Antonetti, F.R.4
-
11
-
-
77956326466
-
Averting inflammation by targeting the cytokine environment
-
CrossRefPubMed
-
Kopf, M.; Bachmann, F.M.; Marsland, J.B. Averting inflammation by targeting the cytokine environment. Nat. Rev. Drug Discov. 2010, 9, 703-718. [CrossRef] [PubMed]
-
(2010)
Nat. Rev. Drug Discov
, vol.9
, pp. 703-718
-
-
Kopf, M.1
Bachmann, F.M.2
Marsland, J.B.3
-
12
-
-
84937000772
-
Interleukin-35: Expanding Its Job Profile
-
CrossRefPubMed
-
Sawant, D.V.; Hamilton, K.; Vignali, D.A.A. Interleukin-35: Expanding Its Job Profile. J. Interferon Cytokine Res. 2015, 35, 499-512. [CrossRef] [PubMed]
-
(2015)
J. Interferon Cytokine Res
, vol.35
, pp. 499-512
-
-
Sawant, D.V.1
Hamilton, K.2
Vignali, D.A.A.3
-
13
-
-
85006154160
-
Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family
-
CrossRefPubMed
-
Hasegawa, H.; Mizoguchi, I.; Chiba, Y.; Ohashi, M.; Xu, M.; Yoshimoto, T. Expanding Diversity in Molecular Structures and Functions of the IL-6/IL-12 Heterodimeric Cytokine Family. Front. Immunol. 2016, 7, 479. [CrossRef] [PubMed]
-
(2016)
Front. Immunol.
, vol.7
, pp. 479
-
-
Hasegawa, H.1
Mizoguchi, I.2
Chiba, Y.3
Ohashi, M.4
Xu, M.5
Yoshimoto, T.6
-
14
-
-
84887447426
-
Bioengineering heterodimeric cytokines: Turning promiscuous proteins into therapeutic agents
-
CrossRefPubMed
-
Belladonna, M.L.; Grohmann, U. Bioengineering heterodimeric cytokines: Turning promiscuous proteins into therapeutic agents. Biotechnol. Genet. Eng. Rev. 2013, 29, 149-174. [CrossRef] [PubMed]
-
(2013)
Biotechnol. Genet. Eng. Rev
, vol.29
, pp. 149-174
-
-
Belladonna, M.L.1
Grohmann, U.2
-
15
-
-
84941942616
-
Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases
-
CrossRefPubMed
-
Egwuagu, C.E.; Yu, C.R.; Sun, L.; Wang, R. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases. Cytokine Growth Factor Rev. 2015, 26, 587-593. [CrossRef] [PubMed]
-
(2015)
Cytokine Growth Factor Rev
, vol.26
, pp. 587-593
-
-
Egwuagu, C.E.1
Yu, C.R.2
Sun, L.3
Wang, R.4
-
16
-
-
36549030784
-
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
-
CrossRefPubMed
-
Collison, L.W.; Workman, C.J.; Kuo, T.T.; Boyd, K.; Wang, Y.; Vignali, K.M.; Cross, R.; Sehy, D.; Blumberg, R.S.; Vignali, D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450, 566-569. [CrossRef] [PubMed]
-
(2007)
Nature
, vol.450
, pp. 566-569
-
-
Collison, L.W.1
Workman, C.J.2
Kuo, T.T.3
Boyd, K.4
Wang, Y.5
Vignali, K.M.6
Cross, R.7
Sehy, D.8
Blumberg, R.S.9
Vignali, D.A.10
-
17
-
-
0030067819
-
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
-
PubMed
-
Devergne, O.; Hummel, M.; Koeppen, H.; Le Beau, M.M.; Nathanson, E.C.; Kieff, E.; Birkenbach, M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 1996, 70, 1143-1153. [PubMed]
-
(1996)
J. Virol
, vol.70
, pp. 1143-1153
-
-
Devergne, O.1
Hummel, M.2
Koeppen, H.3
Le Beau, M.M.4
Nathanson, E.C.5
Kieff, E.6
Birkenbach, M.7
-
18
-
-
84991671415
-
The Immunobiology of IL-35 and its Regulation and Gene Expression
-
CrossRefPubMed
-
Song, M.; Ma, X. The Immunobiology of IL-35 and its Regulation and Gene Expression. Adv. Exp. Med. Biol. 2016, 941, 213-225. [CrossRef] [PubMed]
-
(2016)
Adv. Exp. Med. Biol
, vol.941
, pp. 213-225
-
-
Song, M.1
Ma, X.2
-
19
-
-
84863376362
-
IL-35 is a novel responsive anti-inflammatory cytokine—A new system of categorizing anti-inflammatory cytokines
-
CrossRefPubMed
-
Li, X.; Mai, J.; Virtue, A.; Yin, Y.; Gong, R.; Sha, X.; Gutchigian, S.; Frisch, A.; Hodge, I.; Jiang, X., et al. IL-35 is a novel responsive anti-inflammatory cytokine—A new system of categorizing anti-inflammatory cytokines. PLoS ONE 2012, 7. [CrossRef] [PubMed]
-
(2012)
Plos ONE
, pp. 7
-
-
Li, X.1
Mai, J.2
Virtue, A.3
Yin, Y.4
Gong, R.5
Sha, X.6
Gutchigian, S.7
Frisch, A.8
Hodge, I.9
Jiang, X.10
-
20
-
-
3142709474
-
Understanding the pro- and anti-inflammatory properties of IL-27
-
CrossRefPubMed
-
Villarino, A.V.; Huan, E.; Hunter, C.A. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004, 173, 715-720. [CrossRef] [PubMed]
-
(2004)
J. Immunol
, vol.173
, pp. 715-720
-
-
Villarino, A.V.1
Huan, E.2
Hunter, C.A.3
-
21
-
-
84941941096
-
The biology of interleukin-27 reveals unique pro and anti-inflammatory functions in immunity
-
CrossRefPubMed
-
Aparicio-Siegmund, S.; Gerbers, C. The biology of interleukin-27 reveals unique pro and anti-inflammatory functions in immunity. Cytokine Growth Factor Rev.2015, 26, 579-586. [CrossRef] [PubMed]
-
(2015)
Cytokine Growth Factor Rev
, vol.26
, pp. 579-586
-
-
Aparicio-Siegmund, S.1
Gerbers, C.2
-
22
-
-
78449296907
-
IL-35-mediated induction of a potent regulatory T cell population
-
CrossRefPubMed
-
Collison, L.W.; Chaturvedi, V.; Henderson, A.L.; Giacomin, P.R.; Guy, C.; Bankoti, J.; Finkelstein, D.; Forbes, K.; Workman, C.J.; Brown, S.A., et al. IL-35-mediated induction of a potent regulatory T cell population. Nat. Immunol.2010, 11, 1093-1101. [CrossRef] [PubMed]
-
(2010)
Nat. Immunol
, vol.11
, pp. 1093-1101
-
-
Collison, L.W.1
Chaturvedi, V.2
Henderson, A.L.3
Giacomin, P.R.4
Guy, C.5
Bankoti, J.6
Finkelstein, D.7
Forbes, K.8
Workman, C.J.9
Brown, S.A.10
-
23
-
-
84878586670
-
Human placental trophoblasts express the immunosuppressive cytokine IL-35
-
CrossRefPubMed
-
Mao, H.; Gao, W.; Ma, C.; Sun, J.; Liu, J.; Shao, Q.; Song, B.; Qu, X. Human placental trophoblasts express the immunosuppressive cytokine IL-35. Hum. Immunol. 2013, 74, 872-877. [CrossRef] [PubMed]
-
(2013)
Hum. Immunol
, vol.74
, pp. 872-877
-
-
Mao, H.1
Gao, W.2
Ma, C.3
Sun, J.4
Liu, J.5
Shao, Q.6
Song, B.7
Qu, X.8
-
24
-
-
84947618829
-
IL-35 and Autoimmunity: A Comprehensive Perspective
-
CrossRefPubMed
-
Choi, J.; Leung, P.S.; Bowlus, C.; Gershwin, M.E. IL-35 and Autoimmunity: A Comprehensive Perspective. Clin. Rev. Allergy Immunol. 2015, 49, 327-332. [CrossRef] [PubMed]
-
(2015)
Clin. Rev. Allergy Immunol
, vol.49
, pp. 327-332
-
-
Choi, J.1
Leung, P.S.2
Bowlus, C.3
Gershwin, M.E.4
-
25
-
-
84940480277
-
Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway
-
CrossRefPubMed
-
Sha, X.; Meng, S.; Li, X.; Xi, H.; Maddaloni, M.; Pascual, D.W.; Shan, H.; Jiang, X.; Wang, H.; Yang, X.-F. Interleukin-35 Inhibits Endothelial Cell Activation by Suppressing MAPK-AP-1 Pathway. J. Biol. Chem. 2015, 290, 19307-19318. [CrossRef] [PubMed]
-
(2015)
J. Biol. Chem
, vol.290
, pp. 19307-19318
-
-
Sha, X.1
Meng, S.2
Li, X.3
Xi, H.4
Maddaloni, M.5
Pascual, D.W.6
Shan, H.7
Jiang, X.8
Wang, H.9
Yang, X.-F.10
-
26
-
-
85045340264
-
IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector and blocker in cardiovascular diseases
-
CrossRef
-
Xinyuan, L.; Pu, F.; William, Y.Y.; Hong, W.; Xiaofeng, Y. IL-35, as a newly proposed homeostasis-associated molecular pattern, plays three major functions including anti-inflammatory initiator, effector and blocker in cardiovascular diseases. Cytokine 2017, 6, 003. [CrossRef]
-
(2017)
Cytokine
, vol.6
, pp. 003
-
-
Xinyuan, L.1
Pu, F.2
William, Y.Y.3
Hong, W.4
Xiaofeng, Y.5
-
27
-
-
55149104594
-
Interleukin-35: Odd one out or part of the family?
-
CrossRefPubMed
-
Collison, L.W.; Vignali, D.A.A. Interleukin-35: Odd one out or part of the family? Immunol. Rev. 2008, 226, 248-262. [CrossRef] [PubMed]
-
(2008)
Immunol. Rev
, vol.226
, pp. 248-262
-
-
Collison, L.W.1
Vignali, D.A.A.2
-
28
-
-
84857193362
-
The composition and signaling of the IL-35 receptor are unconventional
-
CrossRefPubMed
-
Collison, L.W.; Delgoffe, G.M.; Guy, C.S.; Vignali, K.M.; Chaturvedi, V.; Fairweather, D.; Satoskar, R.A.; Garcia, C.K.; Hunter, C.A.; Drake, C.G., et al. The composition and signaling of the IL-35 receptor are unconventional. Nat. Immunol. 2012, 13, 290-299. [CrossRef] [PubMed]
-
(2012)
Nat. Immunol
, vol.13
, pp. 290-299
-
-
Collison, L.W.1
Delgoffe, G.M.2
Guy, C.S.3
Vignali, K.M.4
Chaturvedi, V.5
Fairweather, D.6
Satoskar, R.A.7
Garcia, C.K.8
Hunter, C.A.9
Drake, C.G.10
-
29
-
-
78649741783
-
Review gp130 at the nexus of inflammation, autoimmunity and cancer
-
CrossRefPubMed
-
Silver, J.S.; Hunter, C.A. Review gp130 at the nexus of inflammation, autoimmunity and cancer. J. Leukoc. Biol. 2010, 88, 1145-1156. [CrossRef] [PubMed]
-
(2010)
J. Leukoc. Biol
, vol.88
, pp. 1145-1156
-
-
Silver, J.S.1
Hunter, C.A.2
-
30
-
-
84895534422
-
Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance
-
CrossRefPubMed
-
Olson, B.M.; Sullivan, J.A.; Burlingham, W.J. Interleukin 35: A Key Mediator of Suppression and the Propagation of Infectious Tolerance. Front. Immunol. 2013, 4, 315. [CrossRef] [PubMed]
-
(2013)
Front. Immunol
, vol.4
, pp. 315
-
-
Olson, B.M.1
Sullivan, J.A.2
Burlingham, W.J.3
-
31
-
-
0034541139
-
IL-12 receptor β 2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites
-
CrossRefPubMed
-
Wu, C.; Wang, X.; Gadina, M.; O’Shea, J.J.; Presky, D.H.; Magram, J. IL-12 receptor β 2 (IL-12Rβ2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 2000, 165, 6221-6228. [CrossRef] [PubMed]
-
(2000)
J. Immunol
, vol.165
, pp. 6221-6228
-
-
Wu, C.1
Wang, X.2
Gadina, M.3
O’Shea, J.J.4
Presky, D.H.5
Magram, J.6
-
32
-
-
84902078796
-
Interleukin-35 induces regulatory B cells that suppress autoimmune disease
-
CrossRefPubMed
-
Wang, R.X.; Yu, C.R.; Dambuza, I.M.; Mahdi, R.M.; Dolinska, M.B.; Sergeev, Y.V.; Wingfield, P.T.; Kim, S.H.; Egwuagu, C.E. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 2014, 20, 633-641. [CrossRef] [PubMed]
-
(2014)
Nat. Med
, vol.20
, pp. 633-641
-
-
Wang, R.X.1
Yu, C.R.2
Dambuza, I.M.3
Mahdi, R.M.4
Dolinska, M.B.5
Sergeev, Y.V.6
Wingfield, P.T.7
Kim, S.H.8
Egwuagu, C.E.9
-
33
-
-
84897027520
-
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases
-
CrossRefPubMed
-
Shen, P.; Roch, T.; Lampropoulou, V.; O’Connor, R.A.; Stervbo, U.; Hilgenberg, E.; Ries, S.; Dang, D.V.; Jaimes, Y.; Daridon, C., et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014, 507, 366-370. [CrossRef] [PubMed]
-
(2014)
Nature
, vol.507
, pp. 366-370
-
-
Shen, P.1
Roch, T.2
Lampropoulou, V.3
O’Connor, R.A.4
Stervbo, U.5
Hilgenberg, E.6
Ries, S.7
Dang, D.V.8
Jaimes, Y.9
Daridon, C.10
-
34
-
-
84871173673
-
IL-10 produced by iTreg cells controls colitis and pathogenic ex-iTreg cells during immunotherapy
-
CrossRefPubMed
-
Schmitt, E.G.; Haribhai, D.; Williams, J.B.; Aggarwal, P.; Jia, S.; Charbonnier, L.M.; Yan, K.; Lorier, R.; Turner, A.; Ziegelbauer, J., et al. IL-10 produced by iTreg cells controls colitis and pathogenic ex-iTreg cells during immunotherapy. J. Immunol. 2012, 189, 5638-5648. [CrossRef] [PubMed]
-
(2012)
J. Immunol
, vol.189
, pp. 5638-5648
-
-
Schmitt, E.G.1
Haribhai, D.2
Williams, J.B.3
Aggarwal, P.4
Jia, S.5
Charbonnier, L.M.6
Yan, K.7
Lorier, R.8
Turner, A.9
Ziegelbauer, J.10
-
35
-
-
36248970671
-
IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells
-
CrossRefPubMed
-
Niedbala, W.; Wei, X.Q.; Cai, B.; Hueber, A.; Leung, B.P.; McInnes, I.B.; Liew, F.Y. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007, 37, 3021-3029. [CrossRef] [PubMed]
-
(2007)
Eur. J. Immunol
, vol.37
, pp. 3021-3029
-
-
Niedbala, W.1
Wei, X.Q.2
Cai, B.3
Hueber, A.4
Leung, B.P.5
McInnes, I.B.6
Liew, F.Y.7
-
36
-
-
84870018849
-
The treatment strategies of autoimmune disease may need a different approach from conventional protocol. A review
-
CrossRefPubMed
-
Chandrashekara, S. The treatment strategies of autoimmune disease may need a different approach from conventional protocol. A review. Indian J. Pharmacol.2012, 44, 665-671. [CrossRef] [PubMed]
-
(2012)
Indian J. Pharmacol
, vol.44
, pp. 665-671
-
-
Chandrashekara, S.1
-
37
-
-
84937391745
-
-
In Madame Curie Bioscience Database [Internet]; Landes Bioscience: Austin, TX, USA, (accessed on 21 December 2017)
-
Santamaria, P. Cytokines and Chemokines in Autoimmune Disease: An Overview. In Madame Curie Bioscience Database [Internet]; Landes Bioscience: Austin, TX, USA, 2000-2013; Available online: https://www.ncbi.nlm.nih.gov/books/NBK6453 (accessed on 21 December 2017).
-
(2000)
Cytokines and Chemokines in Autoimmune Disease: An Overview
-
-
Santamaria, P.1
-
38
-
-
77953627758
-
+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10
-
CrossRefPubMed
-
+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J. Immunol. 2010, 184, 7144-7153. [CrossRef] [PubMed]
-
(2010)
J. Immunol
, vol.184
, pp. 7144-7153
-
-
Kochetkova, I.1
Golden, S.2
Holderness, K.3
Callis, G.4
Pascual, D.W.5
-
39
-
-
85045309894
-
IL-35 and IL-10 dependent immunoregulatory lymphocytes in Rheumatoid Arthritis
-
Shams, R.; Ali, E.M. IL-35 and IL-10 dependent immunoregulatory lymphocytes in Rheumatoid Arthritis. Sci. J. Immunol. Immunother. 2017, 2, 11-17.
-
(2017)
Sci. J. Immunol. Immunother
, vol.2
, pp. 11-17
-
-
Shams, R.1
Ali, E.M.2
-
40
-
-
0141886186
-
Recent data on the role for angiogenesis in rheumatoid arthritis
-
CrossRef
-
Clavel, G.; Bessis, N.; Boissier, M.C. Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003, 70, 321-326. [CrossRef]
-
(2003)
Joint Bone Spine
, vol.70
, pp. 321-326
-
-
Clavel, G.1
Bessis, N.2
Boissier, M.C.3
-
41
-
-
85006340052
-
IL-35 inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis
-
CrossRefPubMed
-
Jiang, S.; Li, Y.; Lin, T.; Yuan, L.; Li, Y.; Wu, S.; Xia, L.; Shen, H.; Lu, J. IL-35 inhibits Angiogenesis through VEGF/Ang2/Tie2 Pathway in Rheumatoid Arthritis. Cell Physiol. Biochem. 2016, 40, 1105-1116. [CrossRef] [PubMed]
-
(2016)
Cell Physiol. Biochem
, vol.40
, pp. 1105-1116
-
-
Jiang, S.1
Li, Y.2
Lin, T.3
Yuan, L.4
Li, Y.5
Wu, S.6
Xia, L.7
Shen, H.8
Lu, J.9
-
42
-
-
84868589053
-
Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler’s Virus-Induced Demyelinating Disease
-
CrossRefPubMed
-
McCarthy, D.P.; Richards, M.H.; Miller, S.D. Mouse Models of Multiple Sclerosis: Experimental Autoimmune Encephalomyelitis and Theiler’s Virus-Induced Demyelinating Disease. Methods Mol. Biol. 2012, 900, 381-401. [CrossRef] [PubMed]
-
(2012)
Methods Mol. Biol
, vol.900
, pp. 381-401
-
-
McCarthy, D.P.1
Richards, M.H.2
Miller, S.D.3
-
43
-
-
84941553079
-
The pathogenessis of Hashimotos Thyroiditis: Further Developments in our understanding
-
CrossRefPubMed
-
Ajjan, R.A.; Weetman, A.P. The pathogenessis of Hashimotos Thyroiditis: Further Developments in our understanding. Horm. Metab. Res. 2015, 47, 702-710. [CrossRef] [PubMed]
-
(2015)
Horm. Metab. Res
, vol.47
, pp. 702-710
-
-
Ajjan, R.A.1
Weetman, A.P.2
-
44
-
-
84981287970
-
Role of interleukin-35 as a biomarker in patients with newly diagnosed Hashimoto’s Thyroidtis
-
CrossRefPubMed
-
Yilmaz, H.; Cakmak, M.; Ceydilek, B.; Demir, C.; Aktas, A. Role of interleukin-35 as a biomarker in patients with newly diagnosed Hashimoto’s Thyroidtis. Endocr. Regul. 2016, 50, 55-61. [CrossRef] [PubMed]
-
(2016)
Endocr. Regul
, vol.50
, pp. 55-61
-
-
Yilmaz, H.1
Cakmak, M.2
Ceydilek, B.3
Demir, C.4
Aktas, A.5
-
45
-
-
84938493774
-
Interleukin-35 administration counteracts established murine type 1 diabetes—Possible involvement of regulatory T cells
-
CrossRefPubMed
-
Singh, K.; Kadesjo, E.; Lindroos, J.; Hjort, M.; Lundberg, M.; Espes, D.; Carlsson, P.O.; Sandler, S.; Thorvaldson, L. Interleukin-35 administration counteracts established murine type 1 diabetes—Possible involvement of regulatory T cells. Sci. Rep. 2015, 5, 12633. [CrossRef] [PubMed]
-
(2015)
Sci. Rep
, vol.5
, pp. 12633
-
-
Singh, K.1
Kadesjo, E.2
Lindroos, J.3
Hjort, M.4
Lundberg, M.5
Espes, D.6
Carlsson, P.O.7
Sandler, S.8
Thorvaldson, L.9
-
46
-
-
84907246279
-
The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease
-
CrossRefPubMed
-
Li, Y.; Wang, Y.; Liu, Y.; Wang, Y.; Zuo, X.; Li, Y.; Lu, X. The Possible Role of the Novel Cytokines IL-35 and IL-37 in Inflammatory Bowel Disease. Mediat. Inflamm. 2014, 2014. [CrossRef] [PubMed]
-
(2014)
Mediat. Inflamm
, pp. 2014
-
-
Li, Y.1
Wang, Y.2
Liu, Y.3
Wang, Y.4
Zuo, X.5
Li, Y.6
Lu, X.7
-
47
-
-
85045297239
-
Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease
-
CrossRef
-
Camarillo, F.G.; Carballeda, F.J.; Yamamoto-Furusho, J.K. Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease. Cytokine 2015. [CrossRef]
-
(2015)
Cytokine
-
-
Camarillo, F.G.1
Carballeda, F.J.2
Yamamoto-Furusho, J.K.3
-
48
-
-
55849148482
-
The cytokine network in asthma and chronic obstructive pulmonary disease
-
CrossRefPubMed
-
Barnes, P.J. The cytokine network in asthma and chronic obstructive pulmonary disease. J. Clin. Investig. 2008, 118, 3546-3556. [CrossRef] [PubMed]
-
(2008)
J. Clin. Investig
, vol.118
, pp. 3546-3556
-
-
Barnes, P.J.1
-
49
-
-
85006971400
-
IL-35 suppresses Lipopolysaccharide induced airway eosinophilia in Ebi3-deficient mice
-
CrossRefPubMed
-
Kanai, K.; Park, A.M.; Yoshida, H.; Tsunoda, I.; Yoshie, O. IL-35 suppresses Lipopolysaccharide induced airway eosinophilia in Ebi3-deficient mice. J. Immunol. 2017, 198, 119-127. [CrossRef] [PubMed]
-
(2017)
J. Immunol
, vol.198
, pp. 119-127
-
-
Kanai, K.1
Park, A.M.2
Yoshida, H.3
Tsunoda, I.4
Yoshie, O.5
-
50
-
-
20044363972
-
Oncostatin M causes eotaxin-1 release from aairway smooth muscle: Synergy with IL-4 and IL-13
-
CrossRefPubMed
-
Faffe, S.D.; Flynt, L.; Mellema, M.; Moore, E.P.; Silverman, S.E.; Subramaniam, V.M.; Jones, R.M.; Mizgerd, J.P.; Whitehead, T.; Imrich, A., et al. Oncostatin M causes eotaxin-1 release from aairway smooth muscle: Synergy with IL-4 and IL-13. J. Allergy Clin. Immunol. 2005, 115, 514-520. [CrossRef] [PubMed]
-
(2005)
J. Allergy Clin. Immunol
, vol.115
, pp. 514-520
-
-
Faffe, S.D.1
Flynt, L.2
Mellema, M.3
Moore, E.P.4
Silverman, S.E.5
Subramaniam, V.M.6
Jones, R.M.7
Mizgerd, J.P.8
Whitehead, T.9
Imrich, A.10
-
51
-
-
84994388505
-
Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis
-
CrossRefPubMed
-
Suzuki, M.; Yokata, M.; Nakaamura, Y.; Ozaki, S.; Murakami, S. Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis. Allergol. Int. 2017, 66, 351-356. [CrossRef] [PubMed]
-
(2017)
Allergol. Int
, vol.66
, pp. 351-356
-
-
Suzuki, M.1
Yokata, M.2
Nakaamura, Y.3
Ozaki, S.4
Murakami, S.5
-
52
-
-
84911901461
-
Decreased concentration of IL-35 in plasma of patients with asthma and COPD
-
CrossRefPubMed
-
Chen, C.; Deng, Y.; Chen, H.; Wu, X.; Cheng, S.; Xu, Y.; Xiong, W.; Xie, J. Decreased concentration of IL-35 in plasma of patients with asthma and COPD. Asian Pac. J. Allergy Immunol. 2014, 32, 211-217. [CrossRef] [PubMed]
-
(2014)
Asian Pac. J. Allergy Immunol
, vol.32
, pp. 211-217
-
-
Chen, C.1
Deng, Y.2
Chen, H.3
Wu, X.4
Cheng, S.5
Xu, Y.6
Xiong, W.7
Xie, J.8
-
53
-
-
17644412023
-
Mechanisms of disease: Inflammation, atherosclerosis and coronary artery disease
-
CrossRefPubMed
-
Hanson, G.K. Mechanisms of disease: Inflammation, atherosclerosis and coronary artery disease. N. Engl. J. Med. 2005, 352, 1685-1695. [CrossRef] [PubMed]
-
(2005)
N. Engl. J. Med
, vol.352
, pp. 1685-1695
-
-
Hanson, G.K.1
-
54
-
-
85045342845
-
Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters and IL-35 levels: The Genetics of Atherosclerotic Disease (GEA) Study
-
CrossRef
-
Sanchez, P.R.; Hernandez, P.N.; Martines, A.J.; Bautista, L.; Molina, V.T.; Rodriguez-Perez, M.J.; Fragoso, M.J.; Posadas-Romero, C.; Vargas-Alarcon, C. Interleukin 35 polymorphisms are associated with decreased risk of premature coronary artery disease, metabolic parameters and IL-35 levels: The Genetics of Atherosclerotic Disease (GEA) Study. Mediat. Inflamm. 2017, 2017. [CrossRef]
-
(2017)
Mediat. Inflamm
, pp. 2017
-
-
Sanchez, P.R.1
Hernandez, P.N.2
Martines, A.J.3
Bautista, L.4
Molina, V.T.5
Rodriguez-Perez, M.J.6
Fragoso, M.J.7
Posadas-Romero, C.8
Vargas-Alarcon, C.9
-
55
-
-
84871391940
-
Decreased plasma IL-35 are related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases
-
CrossRefPubMed
-
Lin, Y.; Huang, Y.; Lu, Z.; Luo, C.; Shi, Y.; Zeng, Q.; Cao, Y.; Liu, L.; Wang, X.; Ji, Q. Decreased plasma IL-35 are related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases. PLoS ONE 2012. [CrossRef] [PubMed]
-
(2012)
Plos ONE
-
-
Lin, Y.1
Huang, Y.2
Lu, Z.3
Luo, C.4
Shi, Y.5
Zeng, Q.6
Cao, Y.7
Liu, L.8
Wang, X.9
Ji, Q.10
-
56
-
-
84892735965
-
Role of cytokines as a double edged sword in sepsis
-
Chaudhry, H.; Zhou, J.; Zhong, Y.; Ali, M.; McGuire, F.; Nagarkatti, P.; Nagarkatti, M. Role of cytokines as a double edged sword in sepsis. In Vivo 2013, 27, 669-684.
-
(2013)
In Vivo
, vol.27
, pp. 669-684
-
-
Chaudhry, H.1
Zhou, J.2
Zhong, Y.3
Ali, M.4
McGuire, F.5
Nagarkatti, P.6
Nagarkatti, M.7
-
57
-
-
84912573231
-
Interruption of macrophage-derived IL-279p(28) production by IL-10 during sepsis requires STAT3 but not SOCS3
-
CrossRefPubMed
-
Bosman, M.; Russkamp, N.F.; Strobl, B.; Roewe, J.; Balouzian, L.; Pache, F.; Radsak, M.P.; van Rooijen, N.; Zetoune, F.S.; Sarma, J.V., et al. Interruption of macrophage-derived IL-279p(28) production by IL-10 during sepsis requires STAT3 but not SOCS3. J. Immunol. 2014, 193, 5668-5677. [CrossRef] [PubMed]
-
(2014)
J. Immunol
, vol.193
, pp. 5668-5677
-
-
Bosman, M.1
Russkamp, N.F.2
Strobl, B.3
Roewe, J.4
Balouzian, L.5
Pache, F.6
Radsak, M.P.7
Van Rooijen, N.8
Zetoune, F.S.9
Sarma, J.V.10
-
58
-
-
84986880381
-
Interleukin 35: A novel candidate biomarker to diagnose early onset sepsis in neonates
-
CrossRefPubMed
-
Du, W.X.; He, Y.; Jiang, H.Y.; Ai, Q.; Yu, J.L. Interleukin 35: A novel candidate biomarker to diagnose early onset sepsis in neonates. Clin. Chim. Acta 2016, 462, 90-95. [CrossRef] [PubMed]
-
(2016)
Clin. Chim. Acta
, vol.462
, pp. 90-95
-
-
Du, W.X.1
He, Y.2
Jiang, H.Y.3
Ai, Q.4
Yu, J.L.5
-
59
-
-
84983196972
-
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease
-
CrossRefPubMed
-
Tomcik, M.; Zerr, P.; Plumbo-Zerr, K.; Storkanova, H.; Hulejova, H.; Spiritnovic, M.; Kodett, O.; Stork, J.; Becva, R.; Vencovsky, J., et al. Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease. Rheumatology 2015, 54, 2273-2282. [CrossRef] [PubMed]
-
(2015)
Rheumatology
, vol.54
, pp. 2273-2282
-
-
Tomcik, M.1
Zerr, P.2
Plumbo-Zerr, K.3
Storkanova, H.4
Hulejova, H.5
Spiritnovic, M.6
Kodett, O.7
Stork, J.8
Becva, R.9
Vencovsky, J.10
-
60
-
-
84940203172
-
Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement
-
CrossRefPubMed
-
Dantas, A.T.; Gonclaves, S.M.; Pereira, M.C.; Gonclaves, R.S.; Marques, C.D.; Rego, M.J.; Pitta, I.R.; Duarte, A.L.; Pitta, M.G. Increased IL-35 serum levels in systemic sclerosis and association with pulmonary interstitial involvement. J. Clin. Rheumatol. 2015, 34, 1621-1625. [CrossRef] [PubMed]
-
(2015)
J. Clin. Rheumatol
, vol.34
, pp. 1621-1625
-
-
Dantas, A.T.1
Gonclaves, S.M.2
Pereira, M.C.3
Gonclaves, R.S.4
Marques, C.D.5
Rego, M.J.6
Pitta, I.R.7
Duarte, A.L.8
Pitta, M.G.9
-
61
-
-
84947902172
-
Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice
-
CrossRefPubMed
-
Cai, Z.; Wong, C.K.; Dong, J.; Chu, M.; Jiao, D.; Kam, N.W.; Lam, C.W.K.; Tam, L.S. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice. Clin. Exp. Immunol. 2015, 181, 253-266. [CrossRef] [PubMed]
-
(2015)
Clin. Exp. Immunol
, vol.181
, pp. 253-266
-
-
Cai, Z.1
Wong, C.K.2
Dong, J.3
Chu, M.4
Jiao, D.5
Kam, N.W.6
Lam, C.W.K.7
Tam, L.S.8
-
62
-
-
85028857012
-
Hepatitis B virus Reactivation in Patients Receiving Interferon-free Direct-Acting Antiviral Agents for Chronic Hepatitis C virus Infection
-
CrossRefPubMed
-
Liu, C.-H.; Liu, C.-J.; Su, T.-H.; Fang, Y.-J.; Yang, H.-C.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H. Hepatitis B virus Reactivation in Patients Receiving Interferon-free Direct-Acting Antiviral Agents for Chronic Hepatitis C virus Infection. Open Forum Infect. Dis. 2017, 4. [CrossRef] [PubMed]
-
(2017)
Open Forum Infect. Dis
, pp. 4
-
-
Liu, C.-H.1
Liu, C.-J.2
Su, T.-H.3
Fang, Y.-J.4
Yang, H.-C.5
Chen, P.-J.6
Chen, D.-S.7
Kao, J.-H.8
-
63
-
-
84923076268
-
Levels of Interleukin-35 and its relationship with regulatory T-cells in chronic Hepatitis B patients
-
CrossRefPubMed
-
Shi, Y.; Dai, M.; Wu, G.; Zhou, P.; Fang, Y.; Yan, X.B. Levels of Interleukin-35 and its relationship with regulatory T-cells in chronic Hepatitis B patients. Viral Immunol. 2015, 28, 93-100. [CrossRef] [PubMed]
-
(2015)
Viral Immunol
, vol.28
, pp. 93-100
-
-
Shi, Y.1
Dai, M.2
Wu, G.3
Zhou, P.4
Fang, Y.5
Yan, X.B.6
-
64
-
-
84958107720
-
Interleukin-35 limits anti-tumor immunity
-
CrossRefPubMed
-
Turnis, M.E.; Sawant, D.V.; Szymczak-Workman, A.L.; Andrews, L.P.; Delgoffe, G.M.; Yano, H.; Beres, A.J.; Vogel, P.; Workman, C.J.; Vignali, D.A.A. Interleukin-35 limits anti-tumor immunity. Immunity 2016, 44, 316-329. [CrossRef] [PubMed]
-
(2016)
Immunity
, vol.44
, pp. 316-329
-
-
Turnis, M.E.1
Sawant, D.V.2
Szymczak-Workman, A.L.3
Andrews, L.P.4
Delgoffe, G.M.5
Yano, H.6
Beres, A.J.7
Vogel, P.8
Workman, C.J.9
Vignali, D.A.A.10
-
66
-
-
84874275252
-
Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis
-
CrossRefPubMed
-
Wang, Z.; Liu, J.-Q.; Liu, Z.; Shen, R.; Zhang, G.; Xu, J.; Basau, S.; Bai, X.-F. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J. Immunol. 2013, 190, 2415-2423. [CrossRef] [PubMed]
-
(2013)
J. Immunol
, vol.190
, pp. 2415-2423
-
-
Wang, Z.1
Liu, J.-Q.2
Liu, Z.3
Shen, R.4
Zhang, G.5
Xu, J.6
Basau, S.7
Bai, X.-F.8
-
67
-
-
77949425341
-
Regulatory T cells and immune tolerance to tumors
-
CrossRefPubMed
-
Cao, X. Regulatory T cells and immune tolerance to tumors. Immunol. Res. 2010, 46, 79-93. [CrossRef] [PubMed]
-
(2010)
Immunol. Res
, vol.46
, pp. 79-93
-
-
Cao, X.1
-
68
-
-
0032922590
-
Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity
-
CrossRef
-
Borsellino, N.; Bonavida, B.; Ciliberto, G.; Toniatti, C.; Travali, S.; D’Alessandro, N. Blocking signaling through the Gp130 receptor chain by interleukin-6 and oncostatin M inhibits PC-3 cell growth and sensitizes the tumor cells to etoposide and cisplatin-mediated cytotoxicity. Cancer 1999, 85, 134-144. [CrossRef]
-
(1999)
Cancer
, vol.85
, pp. 134-144
-
-
Borsellino, N.1
Bonavida, B.2
Ciliberto, G.3
Toniatti, C.4
Travali, S.5
D’Alessandro, N.6
-
69
-
-
84885362636
-
Assessing the role of IL-35 in colorectal cancer progression and prognosis
-
PubMed
-
Zeng, J.-C.; Zhang, Z.; Li, T.-Y.; Liang, Y.-F.; Wang, H.-M.; Bao, J.-J.; Zhang, J.-A.; Wang, W.-D.; Xiang, W.-Y.; Kong, B., et al. Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int. J. Clin. Exp. Pathol. 2013, 6, 1806-1816. [PubMed]
-
(2013)
Int. J. Clin. Exp. Pathol
, vol.6
, pp. 1806-1816
-
-
Zeng, J.-C.1
Zhang, Z.2
Li, T.-Y.3
Liang, Y.-F.4
Wang, H.-M.5
Bao, J.-J.6
Zhang, J.-A.7
Wang, W.-D.8
Xiang, W.-Y.9
Kong, B.10
-
70
-
-
85045332539
-
Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma
-
CrossRefPubMed
-
Zhang, Y.; Sun, H.; Wu, H.; Tan, Q.; Xiang, K. Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma. Contemp. Oncol. 2015, 119, 120-124. [CrossRef] [PubMed]
-
(2015)
Contemp. Oncol
, vol.119
, pp. 120-124
-
-
Zhang, Y.1
Sun, H.2
Wu, H.3
Tan, Q.4
Xiang, K.5
-
71
-
-
80053474761
-
Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer.
-
CrossRefPubMed
-
Nishino, R.; Takano, A.; Oshita, H.; Ishikawa, N.; Akiyama, H.; Ito, H.; Nakayama, H.; Miyagi, Y.; Tsuchiya, E.; Kohno, N., et al. Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin. Cancer Res. 2011, 17, 6272-6286. [CrossRef] [PubMed]
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 6272-6286
-
-
Nishino, R.1
Takano, A.2
Oshita, H.3
Ishikawa, N.4
Akiyama, H.5
Ito, H.6
Nakayama, H.7
Miyagi, Y.8
Tsuchiya, E.9
Kohno, N.10
-
72
-
-
84979936664
-
IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression
-
CrossRefPubMed
-
Long, J.; Guo, H.; Cui, S.; Zhang, H.; Liu, X.; Li, D.; Ding, Y. IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression. Oncotarget 2017, 7, 45678-45686. [CrossRef] [PubMed]
-
(2017)
Oncotarget
, vol.7
, pp. 45678-45686
-
-
Long, J.1
Guo, H.2
Cui, S.3
Zhang, H.4
Liu, X.5
Li, D.6
Ding, Y.7
-
73
-
-
85045222681
-
Inteleukin-35 expression is associated with colon cancer progression
-
CrossRefPubMed
-
Zhang, J.; Mao, T.; Wang, S.; Wang, D.; Niu, Z.; Sun, Z.; Zhang, J. Inteleukin-35 expression is associated with colon cancer progression. Oncotarget 2017, 8, 71563-71573. [CrossRef] [PubMed]
-
(2017)
Oncotarget
, vol.8
, pp. 71563-71573
-
-
Zhang, J.1
Mao, T.2
Wang, S.3
Wang, D.4
Niu, Z.5
Sun, Z.6
Zhang, J.7
-
74
-
-
85039906124
-
Cytokine profiles in papillary thyroid carcinoma, with or without Hashimoto’s thyroiditis
-
CrossRef
-
Li, F.; Wu, C.; Wang, Y.; He, X.; Zhao, N. Cytokine profiles in papillary thyroid carcinoma, with or without Hashimoto’s thyroiditis. Eur. J. Inflamm. 2017, 1-5. [CrossRef]
-
(2017)
Eur. J. Inflamm
, pp. 1-5
-
-
Li, F.1
Wu, C.2
Wang, Y.3
He, X.4
Zhao, N.5
-
75
-
-
84910062923
-
Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis
-
CrossRefPubMed
-
Liao, K.L.; Bai, X.F.; Friedman, A. Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis. PLoS ONE 2014, 9, e110126. [CrossRef] [PubMed]
-
(2014)
Plos ONE
, pp. 9
-
-
Liao, K.L.1
Bai, X.F.2
Friedman, A.3
-
76
-
-
84883677974
-
New insights in the immunobiology of IL-1 family members
-
CrossRefPubMed
-
Van de Veerdonk, F.L.; Netea, M.G. New insights in the immunobiology of IL-1 family members. Front. Immunol. 2013, 4, 167. [CrossRef] [PubMed]
-
(2013)
Front. Immunol
, vol.4
, pp. 167
-
-
Van De Veerdonk, F.L.1
Netea, M.G.2
-
77
-
-
85011397664
-
Protective role of IL-37 in cancer: A new hope for cancer patients
-
CrossRefPubMed
-
Abulkhir, A.; Samarani, S.; Amre, D.; Duval, M.; Haddad, E.; Sinnett, D.; Leclerc, J.; Diorio, C.; Ahmad, A. A protective role of IL-37 in cancer: A new hope for cancer patients. J. Leukoc. Biol. 2016, 101, 395-406. [CrossRef] [PubMed]
-
(2016)
J. Leukoc. Biol
, vol.101
, pp. 395-406
-
-
Abulkhir, A.1
Samarani, S.2
Amre, D.3
Duval, M.4
Haddad, E.5
Sinnett, D.6
Leclerc, J.7
Diorio, C.8
Ahmad, A.A.9
-
78
-
-
77958149102
-
IL-37 is a fundamental inhibitor of innate immunity
-
CrossRefPubMed
-
Nold, M.F.; Nold-petry, C.A.; Zepp, J.A.; Palmer, B.E.; Bufler, P.; Dinarello, C.A. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 2010, 11, 1014-1022. [CrossRef] [PubMed]
-
(2010)
Nat. Immunol
, vol.11
, pp. 1014-1022
-
-
Nold, M.F.1
Nold-Petry, C.A.2
Zepp, J.A.3
Palmer, B.E.4
Bufler, P.5
Dinarello, C.A.6
-
79
-
-
85042876997
-
Homodimerization attenuates the anti-inflammatory activity of interleukin-37
-
CrossRefPubMed
-
Ellisdon, M.A.; Nold-Petry, C.A.; Laura, D.; Cho, S.X.; Lao, C.J.; Rudloff, I.; Ngo, D.; Lo, C.Y.; Soares da Costa, T.P.; Perugini, M.A., et al. Homodimerization attenuates the anti-inflammatory activity of interleukin-37. Sci. Immunol. 2017, 10, 2. [CrossRef] [PubMed]
-
(2017)
Sci. Immunol
, vol.10
, pp. 2
-
-
Ellisdon, M.A.1
Nold-Petry, C.A.2
Laura, D.3
Cho, S.X.4
Lao, C.J.5
Rudloff, I.6
Ngo, D.7
Lo, C.Y.8
Soares Da Costa, T.P.9
Perugini, M.A.10
-
80
-
-
84965025505
-
Suppression of innate inflammation and immunity by interleukin-37
-
CrossRefPubMed
-
Dinarello, C.A.; Nold-Petry, C.; Nold, M.; Fujita, M.; Li, S.; Kim, S.; Bufler, P. Suppression of innate inflammation and immunity by interleukin-37. Eur. J. Immunol. 2016, 46, 1067-1081. [CrossRef] [PubMed]
-
(2016)
Eur. J. Immunol.
, vol.46
, pp. 1067-1081
-
-
Dinarello, C.A.1
Nold-Petry, C.2
Nold, M.3
Fujita, M.4
Li, S.5
Kim, S.6
Bufler, P.7
-
81
-
-
0038682002
-
Mechanisms of TGF-β signaling from cell membrane to the nucleus
-
CrossRef
-
Shi, Y.; Massague, J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 6, 685-700. [CrossRef]
-
(2003)
Cell
, vol.6
, pp. 685-700
-
-
Shi, Y.1
Massague, J.2
-
82
-
-
0036257305
-
Genomic organization of the interleukin-1 locus
-
CrossRefPubMed
-
Taylor, S.L.; Renshaw, B.R.; Garka, K.E.; Smith, D.E.; Sims, J.E. Genomic organization of the interleukin-1 locus. Genomics 2002, 79, 726-733. [CrossRef] [PubMed]
-
(2002)
Genomics
, vol.79
, pp. 726-733
-
-
Taylor, S.L.1
Renshaw, B.R.2
Garka, K.E.3
Smith, D.E.4
Sims, J.E.5
-
83
-
-
84911092624
-
Immunobiology of Interleukin-37: Mechanism of Action and Clinical Perspectives
-
CrossRefPubMed
-
Quirk, S.; Agrawal, D.K. Immunobiology of Interleukin-37: Mechanism of Action and Clinical Perspectives. Expert Rev. Clin. Immunol. 2014, 10, 1703-1709. [CrossRef] [PubMed]
-
(2014)
Expert Rev. Clin. Immunol
, vol.10
, pp. 1703-1709
-
-
Quirk, S.1
Agrawal, D.K.2
-
84
-
-
84925671141
-
IL-37 requires the receptors IL-18R-α and IL-1R8 (SIGGIR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction
-
CrossRefPubMed
-
Nold-petry, C.A.; Lo, C.Y.; Rudloff, I.; Elgass, K.D.; Li, S.; Gantier, M.D.; Lotz-Havla, A.S.; Gersting, S.W.; Cho, S.X.; Lao, J.C., et al. IL-37 requires the receptors IL-18R-α and IL-1R8 (SIGGIR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 2015, 16, 354-365. [CrossRef] [PubMed]
-
(2015)
Nat. Immunol
, vol.16
, pp. 354-365
-
-
Nold-Petry, C.A.1
Lo, C.Y.2
Rudloff, I.3
Elgass, K.D.4
Li, S.5
Gantier, M.D.6
Lotz-Havla, A.S.7
Gersting, S.W.8
Cho, S.X.9
Lao, J.C.10
-
85
-
-
83055163376
-
IL-37: A new anti-inflammatory cytokine of the IL-1 family
-
CrossRefPubMed
-
Boraschi, D.; Lucchesi, D.; Hainzl, S.; Leitner, M.; Maier, E.; Mangelberger, D.; Oostingh, G.J.; Pfaller, T.; Pixner, C.; Posselt, G., et al. IL-37: A new anti-inflammatory cytokine of the IL-1 family. Eur. Cytokine Netw. 2011, 22, 127-147. [CrossRef] [PubMed]
-
(2011)
Eur. Cytokine Netw
, vol.22
, pp. 127-147
-
-
Boraschi, D.1
Lucchesi, D.2
Hainzl, S.3
Leitner, M.4
Maier, E.5
Mangelberger, D.6
Oostingh, G.J.7
Pfaller, T.8
Pixner, C.9
Posselt, G.10
-
86
-
-
84855585934
-
In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis.
-
CrossRefPubMed
-
Bulau, A.-M.; Fink, M.; Maucksch, C.; Kappler, R.; Mayr, D.; Wagner, K.; Buffler, P. In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis. Sci. World J. 2011, 11, 2480-2490. [CrossRef] [PubMed]
-
(2011)
Sci. World J
, vol.11
, pp. 2480-2490
-
-
Bulau, A.-M.1
Fink, M.2
Maucksch, C.3
Kappler, R.4
Mayr, D.5
Wagner, K.6
Buffler, P.7
-
87
-
-
0036020218
-
Interleukin-1F7b is processed by caspase-1 and mature IL-1F7b binds to the IL-18 receptor but does not induce IFN-γ production
-
CrossRefPubMed
-
Kumar, S.; Hanning, C.R.; Brigham-Burke, M.R.; Rieman, D.J.; Lehr, R.; Khandekar, S.; Kirkpatrick, R.B.; Scott, G.F.; Lee, J.C.; Lynch, F.J., et al. Interleukin-1F7b is processed by caspase-1 and mature IL-1F7b binds to the IL-18 receptor but does not induce IFN-γ production. Cytokine 2002, 2, 61-71. [CrossRef] [PubMed]
-
(2002)
Cytokine
, vol.2
, pp. 61-71
-
-
Kumar, S.1
Hanning, C.R.2
Brigham-Burke, M.R.3
Rieman, D.J.4
Lehr, R.5
Khandekar, S.6
Kirkpatrick, R.B.7
Scott, G.F.8
Lee, J.C.9
Lynch, F.J.10
-
88
-
-
70350004037
-
Increased cytokine production in interleukin-18 receptor α-deficient cells is associated with dysregulation of suppressors of cytokine signaling
-
CrossRefPubMed
-
Nold-Petry, C.A.; Nold, M.F.; Nielsen, J.W.; Bustamante, A.; Zepp, J.A.; Storm, K.A.; Hong, J.-W.; Kim, S.-H.; Dinarello, C.A. Increased cytokine production in interleukin-18 receptor α-deficient cells is associated with dysregulation of suppressors of cytokine signaling. J. Biol. Chem. 2009, 284, 25900-25911. [CrossRef] [PubMed]
-
(2009)
J. Biol. Chem
, vol.284
, pp. 25900-25911
-
-
Nold-Petry, C.A.1
Nold, M.F.2
Nielsen, J.W.3
Bustamante, A.4
Zepp, J.A.5
Storm, K.A.6
Hong, J.-W.7
Kim, S.-H.8
Dinarello, C.A.9
-
89
-
-
77958118283
-
IL-1 family nomenclature
-
CrossRefPubMed
-
Dinarello, C.; Arend, W.; Sims, J.; Smith, D.; Blumberg, H.; O’Niel, L.; Goldbach-Mansky, R.; Pizzarro, T.; Hoffman, H.; Bufler, P., et al. IL-1 family nomenclature. Nat. Immunol. 2010, 11, 973. [CrossRef] [PubMed]
-
(2010)
Nat. Immunol
, vol.11
, pp. 973
-
-
Dinarello, C.1
Arend, W.2
Sims, J.3
Smith, D.4
Blumberg, H.5
O’Niel, L.6
Goldbach-Mansky, R.7
Pizzarro, T.8
Hoffman, H.9
Bufler, P.10
-
90
-
-
84890235827
-
The interleukin-1 family: Back to the future
-
CrossRefPubMed
-
Garlanda, C.; Dinarello, C.A.; Mantovani, A. The interleukin-1 family: Back to the future. Immunity 2013, 39, 1003-1018. [CrossRef] [PubMed]
-
(2013)
Immunity
, vol.39
, pp. 1003-1018
-
-
Garlanda, C.1
Dinarello, C.A.2
Mantovani, A.3
-
91
-
-
80053624991
-
Interleukin 37 expression protects mice from colitis
-
CrossRefPubMed
-
McNamee, E.N.; Masterson, J.C.; Jedlicka, P.; McManus, M.; Grenz, A.; Collins, C.B.; Rivera-Nieves, J. Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA 2011, 108, 16711-16716. [CrossRef] [PubMed]
-
(2011)
Proc. Natl. Acad. Sci. USA
, vol.108
, pp. 16711-16716
-
-
McNamee, E.N.1
Masterson, J.C.2
Jedlicka, P.3
McManus, M.4
Grenz, A.5
Collins, C.B.6
Rivera-Nieves, J.7
-
92
-
-
84996946553
-
Role of anti-inflammatory cytokines IL-35 and IL-37 in Asthma
-
CrossRefPubMed
-
Hu, D. Role of anti-inflammatory cytokines IL-35 and IL-37 in Asthma. Int. J. Inflamm. 2017, 40, 697-707. [CrossRef] [PubMed]
-
(2017)
Int. J. Inflamm.
, vol.40
, pp. 697-707
-
-
Hu, D.1
-
93
-
-
84929650379
-
IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation
-
CrossRefPubMed
-
Ye, L.; Jiang, B.; Deng, J.; Du, J.; Xiong, W.; Guan, Y.; Wen, Z.; Huang, K.; Huang, Z. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation. J. Immunol. 2015, 194, 5110-5119. [CrossRef] [PubMed]
-
(2015)
J. Immunol
, vol.194
, pp. 5110-5119
-
-
Ye, L.1
Jiang, B.2
Deng, J.3
Du, J.4
Xiong, W.5
Guan, Y.6
Wen, Z.7
Huang, K.8
Huang, Z.9
-
94
-
-
84907356510
-
IL-37 protects against obesity-induced inflammation and insulin resistance
-
CrossRefPubMed
-
Ballak, D.B.; Van Diepen, J.A.; Moschen, A.R.; Jansen, H.J.; Hijmans, A.; Groenhof, G.J.; Leenders, F.; Bufler, P.; Boekschoten, M.V.; Müller, M., et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nat. Commun. 2014, 5, 4711. [CrossRef] [PubMed]
-
(2014)
Nat. Commun
, vol.5
, pp. 4711
-
-
Ballak, D.B.1
Van Diepen, J.A.2
Moschen, A.R.3
Jansen, H.J.4
Hijmans, A.5
Groenhof, G.J.6
Leenders, F.7
Bufler, P.8
Boekschoten, M.V.9
Müller, M.10
-
95
-
-
85014161838
-
Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration and improves exercise tolerance
-
CrossRefPubMed
-
Cavalli, G.; Justice, J.N.; Boyle, K.E.; D’Alessandro, A.; Eissenmsser, E.Z.; Jonathan, J.H.; Hansen, K.C.; Nemkov, T.; Stienstra, R.; Garlanda, C., et al. Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration and improves exercise tolerance. Proc. Natl. Acad. Sci. USA 2017. [CrossRef] [PubMed]
-
(2017)
Proc. Natl. Acad. Sci. USA
-
-
Cavalli, G.1
Justice, J.N.2
Boyle, K.E.3
D’Alessandro, A.4
Eissenmsser, E.Z.5
Jonathan, J.H.6
Hansen, K.C.7
Nemkov, T.8
Stienstra, R.9
Garlanda, C.10
-
96
-
-
0037218354
-
Gambotto, A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity
-
CrossRefPubMed
-
Gao, W.; Kumar, S.; Lotze, M.T.; Hanning, C.; Robbins, P.D.; Gambotto, A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity. J. Immunol. 2003, 170, 107-113. [CrossRef] [PubMed]
-
(2003)
J. Immunol
, vol.170
, pp. 107-113
-
-
Gao, W.1
Kumar, S.2
Lotze, M.T.3
Hanning, C.4
Robbins, P.D.5
-
97
-
-
84902076919
-
+ NK cells
-
CrossRefPubMed
-
+ NK cells. Sci. Rep. 2014, 4, 5177-5178. [CrossRef] [PubMed]
-
(2014)
Sci. Rep
, vol.4
, pp. 5177-5178
-
-
Zhao, J.J.1
Pan, Q.Z.2
Pan, K.3
Weng, D.-S.4
Wang, Q.-J.5
Li, J.-J.6
Lv, L.7
Wang, D.-D.8
Zheng, H.-X.9
Jiang, S.-S.10
-
98
-
-
84926327103
-
Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer
-
CrossRefPubMed
-
Wang, W.; Zhao, D.; Zhou, Y.; Hu, X.; Sun, Z.; Yu, G.; Wu, W.-T.; Chen, S.; Kuang, J.-L.; Xu, G.-G., et al. Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer. Acta Pharmacol. Sin. 2015, 36, 528-534. [CrossRef] [PubMed]
-
(2015)
Acta Pharmacol. Sin
, vol.36
, pp. 528-534
-
-
Wang, W.1
Zhao, D.2
Zhou, Y.3
Hu, X.4
Sun, Z.5
Yu, G.6
Wu, W.-T.7
Chen, S.8
Kuang, J.-L.9
Xu, G.-G.10
-
99
-
-
85009740994
-
Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells
-
CrossRefPubMed
-
Luo, C.; Shu, Y.; Luo, J.; Liu, D.; Huang, D.S.; Han, Y.; Chen, C.; Li, Y.C.; Zou, J.M.; Qin, J., et al. Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells. Oncogene 2017, 1-11. [CrossRef] [PubMed]
-
(2017)
Oncogene
, pp. 1-11
-
-
Luo, C.1
Shu, Y.2
Luo, J.3
Liu, D.4
Huang, D.S.5
Han, Y.6
Chen, C.7
Li, Y.C.8
Zou, J.M.9
Qin, J.10
-
100
-
-
84859259668
-
Alterations in the Smad pathway in human cancers. Front
-
CrossRef
-
Samanta, D.; Datta, P.K. Alterations in the Smad pathway in human cancers. Front. Biosci. 2012, 17, 1281-1293. [CrossRef]
-
(2012)
Biosci
, vol.17
, pp. 1281-1293
-
-
Samanta, D.1
Datta, P.K.2
-
101
-
-
85015981268
-
Interleukin-37 in Endometriosis
-
CrossRefPubMed
-
Kaabachi, W.; Kacem, O.; Belhaj, R.; Hamzaoui, A.; Hamzaoui, K. Interleukin-37 in Endometriosis. Immunol. Lett. 2017, 185, 52-55. [CrossRef] [PubMed]
-
(2017)
Immunol. Lett
, vol.185
, pp. 52-55
-
-
Kaabachi, W.1
Kacem, O.2
Belhaj, R.3
Hamzaoui, A.4
Hamzaoui, K.5
-
102
-
-
84862558202
-
Vascular calcification and hypertension: Cause and effect
-
CrossRefPubMed
-
Kalra, S.S.; Shanaham, C. Vascular calcification and hypertension: Cause and effect. Ann. Med. 2012, 44, 85-92. [CrossRef] [PubMed]
-
(2012)
Ann. Med
, vol.44
, pp. 85-92
-
-
Kalra, S.S.1
Shanaham, C.2
-
103
-
-
77955475327
-
+ T cells
-
CrossRefPubMed
-
+ T cells. Blood 2010, 116, 210-217. [CrossRef] [PubMed]
-
(2010)
Blood
, vol.116
, pp. 210-217
-
-
Li, H.1
Hong, S.2
Qian, J.3
Zheng, Y.4
Yang, J.5
Yi, O.6
-
104
-
-
84899642596
-
Coronary artery calcification: Pathogenesis and prognostic implications
-
CrossRefPubMed
-
Madhava, V.M.; Tarigopula, M.; Mintz, S.G.; Maehara, A.; Stone, W.G.; Genereuk, P. Coronary artery calcification: Pathogenesis and prognostic implications. J. Am. Coll. Cardiol. 2014, 63, 1703-1714. [CrossRef] [PubMed]
-
(2014)
J. Am. Coll. Cardiol
, vol.63
, pp. 1703-1714
-
-
Madhava, V.M.1
Tarigopula, M.2
Mintz, S.G.3
Maehara, A.4
Stone, W.G.5
Genereuk, P.6
-
105
-
-
84936993007
-
The protective effect of interleukin-37 on vascular calcification and atherosclerosis in Apolipoprotein E-deficient mice with diabetes
-
CrossRefPubMed
-
Chai, M.; Ji, Q.; Zhang, H.; Zhou, Y.; Yang, Q.; Zhou, Y.; Guo, G.; Liu, W.; Han, W.; Yang, L., et al. The protective effect of interleukin-37 on vascular calcification and atherosclerosis in Apolipoprotein E-deficient mice with diabetes. J. Interferon Cytokine Res. 2015, 35, 530-539. [CrossRef] [PubMed]
-
(2015)
J. Interferon Cytokine Res
, vol.35
, pp. 530-539
-
-
Chai, M.1
Ji, Q.2
Zhang, H.3
Zhou, Y.4
Yang, Q.5
Zhou, Y.6
Guo, G.7
Liu, W.8
Han, W.9
Yang, L.10
-
106
-
-
84937869992
-
Effects of interleukin-37 on cardiac function after myocardial infarction in mice
-
PubMed
-
Xu, D.; Wang, A.; Jiang, F.; Hu, J.; Zhang, X. Effects of interleukin-37 on cardiac function after myocardial infarction in mice. Int. J. Clin. Exp. Pathol. 2015, 8, 5247-5251. [PubMed]
-
(2015)
Int. J. Clin. Exp. Pathol
, vol.8
, pp. 5247-5251
-
-
Xu, D.1
Wang, A.2
Jiang, F.3
Hu, J.4
Zhang, X.5
-
107
-
-
0021447784
-
Sleep promoting effects of endogenous pyrogen (Interleukin-1)
-
CrossRefPubMed
-
Krueger, J.M.; Walter, J.; Dinarello, C.A.; Wolff, S.M.; Chedid, L. Sleep promoting effects of endogenous pyrogen (Interleukin-1). Am. J. Physiol. 1984, 246, R994-R999. [CrossRef] [PubMed]
-
(1984)
Am. J. Physiol
, vol.246
, pp. 994-999
-
-
Krueger, J.M.1
Walter, J.2
Dinarello, C.A.3
Wolff, S.M.4
Chedid, L.5
-
108
-
-
84939269777
-
Tumor necrosis factor enhances the sleep-like state and electrical stimulation induces a wake like state in co-cultures of neurons and glia
-
CrossRefPubMed
-
Jewett, K.A.; Taishi, P.; Sengupta, P.; Roy, S.; Davis, C.J.; Krueger, J.M. Tumor necrosis factor enhances the sleep-like state and electrical stimulation induces a wake like state in co-cultures of neurons and glia. Eur. J. Neurosci. 2015, 42, 2078-2090. [CrossRef] [PubMed]
-
(2015)
Eur. J. Neurosci
, vol.42
, pp. 2078-2090
-
-
Jewett, K.A.1
Taishi, P.2
Sengupta, P.3
Roy, S.4
Davis, C.J.5
Krueger, J.M.6
-
109
-
-
85016445059
-
Interleukin 37 expression in mice alters sleep responses to inflammatory agents and influenza virus infection
-
CrossRefPubMed
-
Davis, C.J.; Zielinski, M.R.; Dunbrasky, D.; Taishi, P.; Dinarello, C.A.; Krueger, J.M. Interleukin 37 expression in mice alters sleep responses to inflammatory agents and influenza virus infection. Neurobiol. Sleep Circadian Rhythm. 2017, 3, 1-9. [CrossRef] [PubMed]
-
(2017)
Neurobiol. Sleep Circadian Rhythm
, vol.3
, pp. 1-9
-
-
Davis, C.J.1
Zielinski, M.R.2
Dunbrasky, D.3
Taishi, P.4
Dinarello, C.A.5
Krueger, J.M.6
-
110
-
-
84890578487
-
Leprosy as a model of immunity
-
CrossRefPubMed
-
Degang, Y.; Nakamura, K.; Akama, T.; Ishido, Y.; Lu, Y.; Ishi, N.; Suzuki, K. Leprosy as a model of immunity. Future Microbiol. 2014, 9, 43-54. [CrossRef] [PubMed]
-
(2014)
Future Microbiol
, vol.9
, pp. 43-54
-
-
Degang, Y.1
Nakamura, K.2
Akama, T.3
Ishido, Y.4
Lu, Y.5
Ishi, N.6
Suzuki, K.7
-
111
-
-
85045574423
-
IL-37 and Leprosy: A novel cytokine involved in the host response to Mycobacterium Leprae infection
-
CrossRefPubMed
-
De Sousa, R.J.; Prudente, R.R.; Dias Junior, L.B.; Oliveira Carneiro, F.R.; Sotto, M.N.; Simoes Quaresma, J.A. IL-37 and Leprosy: A novel cytokine involved in the host response to Mycobacterium Leprae infection. Cytokine 2017, S1043-S4666. [CrossRef] [PubMed]
-
(2017)
Cytokine
, pp. 1043-4666
-
-
De Sousa, R.J.1
Prudente, R.R.2
Dias Junior, L.B.3
Oliveira Carneiro, F.R.4
Sotto, M.N.5
Simoes Quaresma, J.A.6
-
112
-
-
84942865248
-
+regulatory T cells
-
CrossRefPubMed
-
+regulatory T cells. Sci. Rep. 2015, 5, 14478. [CrossRef] [PubMed]
-
(2015)
Sci. Rep
, vol.5
, pp. 14478
-
-
Shuai, X.1
Wei-Min, L.2
Tong, Y.L.3
Dong, N.4
Sheng, Z.Y.5
Yao, Y.M.6
|